Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer (Q39428841)

11 September 2017

Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer (English)

1 reference

11 September 2017

1 reference

Dan Guo

1

1 reference

PubMed ID

22167620

11 September 2017

Jiayi Huang

series ordinal

2

1 reference

PubMed ID

22167620

11 September 2017

Jianping Gong

series ordinal

3

1 reference

11 September 2017

14 December 2011

1 reference

Molecular and Cellular Biochemistry

11 September 2017

1 reference

11 September 2017

363

1 reference

11 September 2017

1-2

1 reference

11 September 2017

179-190

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-1170-1

11 September 2017

0 references

cites work

Overview of bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Bone morphogenetic proteins: multifunctional regulators of vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A protocol for rapid generation of recombinant adenoviruses using the AdEasy system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Establishment and characterization of a new highly metastatic human osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Functional implication of BMP4 expression on angiogenesis in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Matrix metalloproteinases (MMPs) in health and disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

CXCR4 expression in early breast cancer and risk of distant recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Functions of RANKL/RANK/OPG in bone modeling and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1170-1

Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)

21 January 2018

1 reference

12 December 2020

Activity of MMP-2 and MMP-9 in sera of breast cancer patients

1 reference

12 December 2020

S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.

1 reference

12 December 2020

Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors

1 reference

12 December 2020

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells

1 reference

12 December 2020

Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.

1 reference

12 December 2020

[Effect of small interfering RNA targeting CXCR4 on breast cancer angiogenesis]

1 reference

12 December 2020

Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer

1 reference

12 December 2020

Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells

1 reference

12 December 2020

[RANKL and OPG regulation on bone remodeling]

1 reference

12 December 2020

CXCR4 as a predictive marker for locally advanced breast cancer post-neoadjuvant therapy

1 reference

12 December 2020

KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9.

1 reference

12 December 2020

Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA

1 reference

12 December 2020

[The effects of shRNA-CXCR4 on breast cancer cells migration and invasion]

1 reference

12 December 2020

Chemokine receptor CXCR4 overexpression predicts recurrence for hormone receptor-positive, node-negative breast cancer patients.

1 reference

12 December 2020

Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer

1 reference

12 December 2020

Risk of complications from bone metastases in breast cancer. implications for management

1 reference

12 December 2020

Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.

1 reference

12 December 2020

10.1007/S11010-011-1170-1

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

22167620